A new drug combination shows unexpected synergy against liver fibrosis. A new study reveals that using two drugs together ...

Vials of drug The efficacy of many combination therapies may be due to independent drug action, not synergistic or additive effects. Although combination treatments that include immune checkpoint ...

A research team reports a promising new strategy: combining two already-approved drugs—silybin, a natural liver-protective compound, and carvedilol, a widely used cardiovascular medicine—to powerfully ...

Independent drug action, not synergy nor additivity, accounted for the clinical efficacy of nearly all examined combination therapies involving immune checkpoint inhibitors in clinical trials, ...

Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...

Prospective phase II trial of a combination of gemcitabine, cisplatin and UFT as first-line treatment in patients with advanced, unresectable, non-small cell lung carcinoma ...

A new combination drug treatment for parasitic intestinal roundworms shows promise in a test on a common laboratory species. Several drugs currently in use or in development control parasitic worms in ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of ...